[HTML][HTML] Measurable residual disease in chronic myeloid leukemia
S Branford, JF Apperley - Haematologica, 2022 - ncbi.nlm.nih.gov
Chronic myeloid leukemia is characterized by a single genetic abnormality resulting in a
fusion gene whose mRNA product is easily detected and quantified by reverse-transcriptase …
fusion gene whose mRNA product is easily detected and quantified by reverse-transcriptase …
A review on characterization of BCR–ABL transcript variants for molecular monitoring of chronic myeloid leukemia phenotypes
Chronic myeloid leukemia (CML) is a clonal myeloproliferative growth of human pluripotent
stem cells which is estimated to occur at a rate of 1/100000 populations every year …
stem cells which is estimated to occur at a rate of 1/100000 populations every year …